+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Respiratory Care Devices Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 197 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 5675118
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Healthcare organizations are navigating significant shifts in the respiratory care devices market, focusing on digital transformation and adaptable solutions to advance patient outcomes and operational effectiveness. Leaders face complex demands around regulatory change, technology uptake, and tailored care delivery in increasingly diverse healthcare environments.

Market Snapshot: Respiratory Care Devices Market Overview

In 2024, the global respiratory care devices market reached USD 22.53 billion, with growth sustained by a compound annual growth rate (CAGR) of 8.67%. Digital innovation remains central, as organizations invest in remote-ready and interoperable respiratory solutions, reflecting a clear shift toward streamlined clinical workflows, integrated patient data, and enhanced engagement. These trends are reinforced by evolving regulatory landscapes and payer priorities that influence technology adoption and care models across different healthcare systems and regions.

Scope & Segmentation in the Respiratory Care Devices Market

This report offers comprehensive, segment-level analysis designed to guide senior executives in optimizing investment, operational efficiency, and regional adaptation. Each market segment is examined for its potential impact on provider strategy, technology integration, and patient care amidst rising complexity and localization in respiratory health management.

  • Product Type: Diagnosis devices, monitoring systems, therapy machines, consumables, and accessories, each addressing specific needs in acute and long-term respiratory care environments.
  • Consumables & Accessories: Items such as breathing circuits, patient masks, nasal cannulas, and tracheostomy tubes contribute to infection control and safety across hospitals, homecare, and community settings.
  • Diagnostic Devices: Peak flow meters, sleep apnea monitors, and spirometers support early disease detection and continuous monitoring, driving consistent care quality in both clinical and remote settings.
  • Monitoring Devices: Capnographs and pulse oximeters deliver real-time clinical information, improving clinical decision-making in on-site and digital care scenarios.
  • Therapeutic Devices: Devices including humidifiers, nebulizers, oxygen concentrators, and positive airway pressure systems enable customized treatment plans for a spectrum of respiratory conditions.
  • Patient Group: Solutions are tailored to the distinct needs of adult, pediatric, neonatal, and geriatric patients, supporting improved therapy adherence and health outcomes for all age groups.
  • Indication: Devices are utilized in cases of acute respiratory distress, asthma, COPD, and sleep-related disorders, enhancing precision in diverse clinical applications.
  • Sales Channel: Both online and offline procurement channels help ensure broad supply chain access for a range of healthcare providers and facilities.
  • End User: Respiratory devices are widely implemented by hospitals, clinics, ambulatory and diagnostic centers, and homecare organizations—demonstrating flexibility across care environments.
  • Region: Coverage extends across the Americas, EMEA, and Asia-Pacific, recognizing regulatory and technological differences that influence adoption and operational models regionally.
  • Leading Companies Analyzed: Key competitors such as ResMed Corp., Baxter International, Philips, Medtronic, Teleflex, and GE HealthCare Technologies set market benchmarks for strategy and positioning.

Key Takeaways for Senior Decision-Makers

  • Rapid digitalization of monitoring and diagnostic solutions is expanding the reach of respiratory care across facility types and patient locations.
  • Integration with telemedicine and electronic health records is elevating continuity of care and supporting more coordinated, outcomes-driven care pathways.
  • The rise of portable respiratory devices provides clinicians with greater flexibility, enabling responsive intervention in both acute centers and decentralized care settings, including patient homes.
  • Supplier diversity and emphasis on locally oriented sourcing strategies are emerging as responses to supply chain volatility and regulatory adaptation.
  • Strong portfolio management combined with compliance to localized regulatory standards is facilitating effective entry and long-term presence in regional markets—both established and emerging.
  • Ensuring operational continuity calls for refined procurement tactics, as external disruptions can introduce risk into global device availability and distribution.

Tariff Impact on Supply Chains

Recent changes in tariff structures and related regulatory policies are motivating manufacturers to increase reliance on regional sourcing and build agile supplier partnerships. These shifts are enabling greater stability in device availability and equipping organizations to quickly adapt to new trade conditions and evolving procurement demands.

Methodology & Data Sources

This research draws on direct interviews with sector leaders, augmented by secondary data analysis and validation against trusted industry benchmarks. The approach is designed to ensure insights are actionable and directly relevant to executive-level planning within the changing respiratory care landscape.

Why This Report Matters

  • Empowers executive teams to address shifting regulatory, operational, and procurement priorities with focused, data-driven recommendations drawn from real industry trends.
  • Guides development of agile product offerings and supply chain strategies, supporting preparedness for regulatory shifts and evolving care delivery expectations across major markets.
  • Encourages investment in advanced segmentation and ongoing technology integration, which underpin improved clinical quality and sustainable operational performance for healthcare organizations.

Conclusion

The respiratory care devices market is poised for continued transformation as organizations embrace digital approaches and reinforce supply chain resilience. Leaders who proactively adapt to these shifts will secure operational stability and competitive growth in this dynamic sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Integration of smart inhaler platforms with real-time patient adherence monitoring
5.2. Increasing adoption of high-flow nasal cannula therapy for acute respiratory distress management
5.3. Rise of AI-driven home ventilator systems offering predictive respiratory pattern analysis
5.4. Development of antiviral filtration modules in nebulizers to curb airborne pathogen spread
5.5. Expansion of telehealth integrated CPAP and BiPAP devices for remote patient monitoring
5.6. Surge in demand for eco-friendly disposable respiratory masks with biodegradable materials
5.7. Stringent cybersecurity regulations driving design changes in connected respiratory devices architecture
5.8. Closed-loop oxygen therapy with automated FiO2 titration integrated into bedside monitors to reduce hypoxemia
5.9. Transition from jet to mesh nebulizers in hospitals to enhnace drug deposition, shorten treatment times
5.10. EU MDR and UKCA compliance demands elevating clinical evidence generation for respiratory care devices
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Respiratory Care Devices Market, by Product Type
8.1. Consumables & Accessories
8.1.1. Breathing Circuits
8.1.2. Masks
8.1.3. Nasal Cannulas
8.1.4. Tracheostomy Tubes
8.2. Diagnostic Devices
8.2.1. Peak Flow Meters
8.2.2. Polysomnography Devices
8.2.3. Spirometers
8.3. Monitoring Devices
8.3.1. Capnographs
8.3.2. Pulse Oximeters
8.4. Therapeutic Devices
8.4.1. Humidifiers
8.4.2. Nebulizers
8.4.3. Oxygen Concentrators
8.4.4. Positive Airway Pressure Devices
9. Respiratory Care Devices Market, by Patient Group
9.1. Adult
9.2. Geriatric
9.3. Neonatal
9.4. Pediatric
10. Respiratory Care Devices Market, by Indication
10.1. Acute Respiratory Distress Syndrome
10.2. Asthma
10.3. Chronic Obstructive Pulmonary Disease
10.4. Sleep Apnea
11. Respiratory Care Devices Market, by Sales Channel
11.1. Offline Sales
11.2. Online Sales
12. Respiratory Care Devices Market, by End User
12.1. Ambulatory Care Centers
12.2. Diagnostic Centers
12.3. Homecare Settings
12.4. Hospitals & Clinics
13. Respiratory Care Devices Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Respiratory Care Devices Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Respiratory Care Devices Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. ResMed Corp.
16.3.2. Baxter International, Inc.
16.3.3. Allied Medical LLC
16.3.4. Catalent, Inc.
16.3.5. Getinge AB
16.3.6. Hamilton Medical AG
16.3.7. Invacare Corporation
16.3.8. Koninklijke Philips N.V.
16.3.9. Medtronic PLC
16.3.10. Omron Corporation
16.3.11. Schiller AG
16.3.12. Smiths Group PLC
16.3.13. Teleflex Incorporated
16.3.14. Thermo Fisher Scientific Inc.
16.3.15. Drägerwerk AG & Co. KGaA
16.3.16. Fisher & Paykel Healthcare Limited
16.3.17. GE HealthCare Technologies Inc.
16.3.18. L’Air Liquide S.A.
16.3.19. Masimo Corporation
16.3.20. Max Ventilator Pvt. Ltd.
16.3.21. Medline Industries, LP
16.3.22. Nihon Kohden Corporation
16.3.23. Nonin Medical, Inc.
16.3.24. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
16.3.25. Löwenstein Medical SE & Co. KG
16.3.26. WEINMANN Emergency Medical Technology GmbH + Co. KG

Companies Mentioned

The companies profiled in this Respiratory Care Devices market report include:
  • ResMed Corp.
  • Baxter International, Inc.
  • Allied Medical LLC
  • Catalent, Inc.
  • Getinge AB
  • Hamilton Medical AG
  • Invacare Corporation
  • Koninklijke Philips N.V.
  • Medtronic PLC
  • Omron Corporation
  • Schiller AG
  • Smiths Group PLC
  • Teleflex Incorporated
  • Thermo Fisher Scientific Inc.
  • Drägerwerk AG & Co. KGaA
  • Fisher & Paykel Healthcare Limited
  • GE HealthCare Technologies Inc.
  • L’Air Liquide S.A.
  • Masimo Corporation
  • Max Ventilator Pvt. Ltd.
  • Medline Industries, LP
  • Nihon Kohden Corporation
  • Nonin Medical, Inc.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Löwenstein Medical SE & Co. KG
  • WEINMANN Emergency Medical Technology GmbH + Co. KG

Table Information